Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Regenerx Biopharmaceuticals market cap is $2.71M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Regenerx Biopharmaceuticals 52 week high is $18.99 as of September 24, 2023.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Regenerx Biopharmaceuticals 52 week low is $0.013 as of September 24, 2023.
Regenerx Biopharmaceuticals stock price today is $0.0182.
Regenerx Biopharmaceuticals stock price yesterday was $0.0181.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Regenerx Biopharmaceuticals’s P/E ratio is -1.54.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Regenerx Biopharmaceuticals P/B ratio is -0.6979.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Regenerx Biopharmaceuticals's EBITDA is -12.08.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Regenerx Biopharmaceuticals 50-day moving average is $1.24.
Regenerx Biopharmaceuticals has 2 employees.
3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here.